We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+37.47%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$343M
AUM Growth
+$44.3M
Cap. Flow
-$16.4M
Cap. Flow %
-4.77%
Top 10 Hldgs %
36.95%
Holding
100
New
31
Increased
17
Reduced
28
Closed
22

Top Buys

Rank Stock Value
1
SOLY
Soliton, Inc.
SOLY
+$10.1M
2
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$9.42M
3
GLD icon
SPDR Gold Trust
GLD
+$9.03M
4
RCM
R1 RCM Inc. Common Stock
RCM
+$7.85M
5
COR icon
Cencora
COR
+$7.79M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$21.5M
2
NVST icon
Envista
NVST
+$12.8M
3
BSX icon
Boston Scientific
BSX
+$10.2M
4
AGN
Allergan plc
AGN
+$9.74M
5
BIIB icon
Biogen
BIIB
+$8.46M

Sector Composition

Rank Sector Weight
1 Healthcare 81.41%
2 Miscellaneous 15.19%
3 Industrials 2.48%
4 Financials 0.92%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHRS icon
1
Coherus Oncology
CHRS
$218M
$20.3M 5.92%
1,135,863
+58,024
+5% +$982K
GLD icon
2
SPDR Gold Trust
GLD
$149B
$20.2M 5.9%
120,702
+56,000
+87% +$9.03M
MCK icon
3
McKesson
MCK
$104B
$14.9M 4.36%
97,285
-35,055
-26% -$5.06M
TEVA icon
4
Teva Pharmaceuticals
TEVA
$42.5B
$11.9M 3.46%
962,796
+390,115
+68% +$4.41M
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$11.7M 3.4%
94,984
-73,060
-43% -$8.29M
COR icon
6
Cencora
COR
$61.5B
$10.1M 2.96%
100,545
+84,617
+531% +$7.79M
MOH icon
7
Molina Healthcare
MOH
$10.4B
$10.1M 2.95%
56,807
+20,834
+58% +$3.55M
HRC
8
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$9.88M 2.88%
+90,000
New +$9.42M
MRK icon
9
Merck
MRK
$366B
$8.84M 2.58%
119,839
+22,288
+23% +$1.68M
MRSN
10
DELISTED
Mersana Therapeutics
MRSN
$8.7M 2.54%
14,871
+8,221
+124% +$2.81M
RCM
11
DELISTED
R1 RCM Inc. Common Stock
RCM
$8.51M 2.48%
+763,023
New +$7.85M
ELV icon
12
Elevance Health
ELV
$85.5B
$8.37M 2.44%
31,819
-26,050
-45% -$6.95M
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
$8.03M 2.34%
2,299,982
+2,167,508
+1,636% +$6.25M
SOLY
14
DELISTED
Soliton, Inc.
SOLY
$7.97M 2.33%
+1,025,000
New +$10.1M
HCA icon
15
HCA Healthcare
HCA
$90.5B
$7.93M 2.32%
81,732
+3,800
+5% +$395K
UTHR icon
16
United Therapeutics
UTHR
$22.1B
$7.89M 2.3%
65,210
-25,613
-28% -$2.88M
LLY icon
17
Eli Lilly
LLY
$1.05T
$7.54M 2.2%
+45,901
New +$7.05M
MESO
18
PUT
Mesoblast
MESO
$2.26B
$7.3M 2.13%
320,600
+316,550
+7,816% +$6.78M
CAH icon
19
Cardinal Health
CAH
$54.6B
$6.97M 2.03%
+133,500
New +$6.88M
BMY.RT
20
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$6.16M 1.8%
1,719,271
-527,629
-23% -$1.9M
OFIX icon
21
Orthofix Medical
OFIX
$395M
$6.14M 1.79%
+191,891
New +$6.37M
ARNA
22
DELISTED
Arena Pharmaceuticals Inc
ARNA
$5.99M 1.75%
95,153
+10,000
+12% +$550K
OSUR icon
23
OraSure Technologies
OSUR
$248M
$5.35M 1.56%
+460,000
New +$5.97M
WBA
24
DELISTED
Walgreens Boots Alliance
WBA
$5.26M 1.54%
+124,194
New +$5.27M
CRIS icon
25
Curis
CRIS
$3.61M
$5.2M 1.52%
+10,750
New +$3.96M
1
2 3 4

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Sio Capital Management held 100 positions worth $343M, up 15% from $298M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sio Capital Management withdrew a net $16.4M in Q2 2020, closing 22 positions and reducing 28 holdings. Its most notable exit was Amgen, an estimated $21.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 86% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, Sio Capital Management opened a new position in Soliton, Inc. worth $7.97M.

  • Sio Capital Management's largest Q2 2020 buy was Soliton, Inc.: 1,025,000 shares worth $7.97M.
  • Sio Capital Management added most to SPDR Gold Trust in Q2 2020, an estimated $9.03M increase.
  • Sio Capital Management's biggest Q2 2020 reduction was Boston Scientific, cutting an estimated $10.2M.
  • Sio Capital Management fully exited Amgen in Q2 2020, selling an estimated $21.5M.
  • Sio Capital Management's ten largest holdings make up 37% of its $343M portfolio in Q2 2020.
  • Sio Capital Management opened 31 new positions and closed 22 in Q2 2020.
  • Sio Capital Management's portfolio value rose 15% quarter-over-quarter to $343M.

Based on Sio Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.